<DOC>
	<DOC>NCT01687985</DOC>
	<brief_summary>A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.</brief_summary>
	<brief_title>A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Cathartics</mesh_term>
	<criteria>Male or female subjects at least 18 years of age Constipated, defined by ROME definition: Otherwise in good health, as determined by physical exam and medical history Subjects with known or suspected ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon Subjects taking laxatives or prokinetic agents that refuse to discontinue these treatments Subjects who are allergic to any BLI801 component Subjects currently taking narcotic analgesics or other medications known to cause constipation Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures Subjects who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days Subjects with an active history of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>